Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
The benchmark indices and broader markets have rallied more than 55 percent from the lows of March 23, though they have been some correction in the last few sessions.
In the coming months, the broader markets will outperform the benchmarks if the growth comes back on track, say experts.
Last week, Nifty gyrated in a slender range of merely 160 points. Amid all this, the benchmark index concluded the week with moderate gains of one and half a percent.
The broader markets also traded in line with benchmark indices as the BSE Midcap index gained 35 percent and Smallcap index rose 40 percent.
These stocks may take off once the runway is clear, says the brokerage.
Laurus reported a strong set of results for Q4FY2020 with PAT at Rs 109.6 crore, growing 154 percent YoY and slightly ahead of Sharekhan's estimates.
On the technical front, 8,800 levels would act as a major support for Nifty below which we could see further long liquidation which could drag the index towards 8,600 levels in the coming sessions.
The panic created by COVID-19 has taken a heavy toll on most sectors but pharma companies seem to have withstood the carnage, with some stocks delivering healthy returns during this period.
Correction is expected to continue, but this is the right time to accumulate quality stocks, most of experts feel
A lot of stocks have shown double digit growth in the last few sessions but it is never too late to invest, provided it is done after a thorough research.
Overall, especially after the run in November, the market has been rangebound and stock-specific action has continued, which is likely to be the top theme in the rest of 2019 as well
Failure to cross 11,100 can trigger profit booking dragging the Index lower to levels of 10,500-10,250. The Bank Nifty is also showing strength making new highs which can take the headline Index Nifty to 11,100 to 11,400 levels.
CLSA says HDFC remains its top pick in financials segment as the expansion of subsidy scheme by government is positive for housing finance companies.
Mitesh Thacker of miteshthacker.com recommends buying Indo Count Industries and Laurus Labs.
In an interview to CNBC-TV18 SP Tulsian of sptulsian.com shares what is a a good level to enter the Glenmark pharma stock. He also shares his view on other stocks like Laurus Labs, which listed today, defence picks like Bharat Forge, and agro companies like Jayant Agro.